FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120667790> ?p ?o ?g. }

• W2120667790 abstract "About 10 to 20% of children in West European countries have atopic dermatitis (AD), often as part of the atopic syndrome. The full atopic syndrome also consists of allergic asthma, allergic rhinitis and food allergy. Treatment approaches for atopic dermatitis and asthma include intermittent anti-inflammatory therapy with corticosteroids, health education and self-management training. However, symptoms persist in a subgroup of patients. Several observational studies have shown significant improvement in clinical symptoms in children and adults with atopic dermatitis or asthma after treatment at high altitude, but evidence on the efficacy when compared to treatment at sea level is still lacking. This study is a pragmatic randomized controlled trial for children with moderate to severe AD within the atopic syndrome. Patients are eligible for enrolment in the study if they are: diagnosed with moderate to severe AD within the atopic syndrome, aged between 8 and 18 years, fluent in the Dutch language, have internet access at home, able to use the digital patient system Digital Eczema Center Utrecht (DECU), willing and able to stay in Davos for a six week treatment period. All data are collected at the Wilhelmina Children’s Hospital and DECU. Patients are randomized over two groups. The first group receives multidisciplinary inpatient treatment during six weeks at the Dutch Asthma Center in Davos, Switzerland. The second group receives multidisciplinary treatment during six weeks at the outpatient clinic of the Wilhelmina Children’s Hospital, Utrecht, the Netherlands. The trial is not conducted as a blind trial. The trial is designed with three components: psychosocial, clinical and translational. Primary outcomes are coping with itch, quality of life and disease activity. Secondary outcomes include asthma control, medication use, parental quality of life, social and emotional wellbeing of the child and translational parameters. The results of this trial will provide evidence for the efficacy of high altitude treatment compared to treatment at sea level for children with moderate to severe AD. Current Controlled Trials ISRCTN88136485 ." @default.
• W2120667790 created "2016-06-24" @default.
• W2120667790 creator A5035356790 @default.
• W2120667790 creator A5038098443 @default.
• W2120667790 creator A5039258648 @default.
• W2120667790 creator A5044488136 @default.
• W2120667790 creator A5045066397 @default.
• W2120667790 creator A5050598913 @default.
• W2120667790 creator A5056901976 @default.
• W2120667790 creator A5061643146 @default.
• W2120667790 creator A5090630130 @default.
• W2120667790 date "2014-03-26" @default.
• W2120667790 modified "2023-10-16" @default.
• W2120667790 title "Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial)" @default.
• W2120667790 cites W1569788030 @default.
• W2120667790 cites W1776228394 @default.
• W2120667790 cites W1971402668 @default.
• W2120667790 cites W1980648588 @default.
• W2120667790 cites W1983695621 @default.
• W2120667790 cites W1987685875 @default.
• W2120667790 cites W2022137053 @default.
• W2120667790 cites W2024687543 @default.
• W2120667790 cites W2027321813 @default.
• W2120667790 cites W2043302662 @default.
• W2120667790 cites W2049846475 @default.
• W2120667790 cites W2058681121 @default.
• W2120667790 cites W2059517841 @default.
• W2120667790 cites W2065545338 @default.
• W2120667790 cites W2065926781 @default.
• W2120667790 cites W207032901 @default.
• W2120667790 cites W2074461433 @default.
• W2120667790 cites W2076210324 @default.
• W2120667790 cites W2087760311 @default.
• W2120667790 cites W2088679944 @default.
• W2120667790 cites W2098480313 @default.
• W2120667790 cites W2098581610 @default.
• W2120667790 cites W2102471539 @default.
• W2120667790 cites W2108361431 @default.
• W2120667790 cites W2116889630 @default.
• W2120667790 cites W2117359358 @default.
• W2120667790 cites W2118916692 @default.
• W2120667790 cites W2122930857 @default.
• W2120667790 cites W2134261811 @default.
• W2120667790 cites W2142641157 @default.
• W2120667790 cites W2149086737 @default.
• W2120667790 cites W2154552512 @default.
• W2120667790 cites W2160302514 @default.
• W2120667790 cites W2166145306 @default.
• W2120667790 cites W2167562147 @default.
• W2120667790 cites W2318321866 @default.
• W2120667790 cites W4211044813 @default.
• W2120667790 cites W4292806894 @default.
• W2120667790 doi "https://doi.org/10.1186/1745-6215-15-94" @default.
• W2120667790 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3975250" @default.
• W2120667790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24670079" @default.
• W2120667790 hasPublicationYear "2014" @default.
• W2120667790 type Work @default.
• W2120667790 sameAs 2120667790 @default.
• W2120667790 citedByCount "10" @default.
• W2120667790 countsByYear W21206677902017 @default.
• W2120667790 countsByYear W21206677902018 @default.
• W2120667790 countsByYear W21206677902019 @default.
• W2120667790 countsByYear W21206677902020 @default.
• W2120667790 countsByYear W21206677902022 @default.
• W2120667790 crossrefType "journal-article" @default.
• W2120667790 hasAuthorship W2120667790A5035356790 @default.
• W2120667790 hasAuthorship W2120667790A5038098443 @default.
• W2120667790 hasAuthorship W2120667790A5039258648 @default.
• W2120667790 hasAuthorship W2120667790A5044488136 @default.
• W2120667790 hasAuthorship W2120667790A5045066397 @default.
• W2120667790 hasAuthorship W2120667790A5050598913 @default.
• W2120667790 hasAuthorship W2120667790A5056901976 @default.
• W2120667790 hasAuthorship W2120667790A5061643146 @default.
• W2120667790 hasAuthorship W2120667790A5090630130 @default.
• W2120667790 hasBestOaLocation W21206677901 @default.
• W2120667790 hasConcept C126322002 @default.
• W2120667790 hasConcept C16005928 @default.
• W2120667790 hasConcept C168563851 @default.
• W2120667790 hasConcept C1862650 @default.
• W2120667790 hasConcept C187212893 @default.
• W2120667790 hasConcept C23131810 @default.
• W2120667790 hasConcept C2776042228 @default.
• W2120667790 hasConcept C2778329239 @default.
• W2120667790 hasConcept C535046627 @default.
• W2120667790 hasConcept C71924100 @default.
• W2120667790 hasConceptScore W2120667790C126322002 @default.
• W2120667790 hasConceptScore W2120667790C16005928 @default.
• W2120667790 hasConceptScore W2120667790C168563851 @default.
• W2120667790 hasConceptScore W2120667790C1862650 @default.
• W2120667790 hasConceptScore W2120667790C187212893 @default.
• W2120667790 hasConceptScore W2120667790C23131810 @default.
• W2120667790 hasConceptScore W2120667790C2776042228 @default.
• W2120667790 hasConceptScore W2120667790C2778329239 @default.
• W2120667790 hasConceptScore W2120667790C535046627 @default.
• W2120667790 hasConceptScore W2120667790C71924100 @default.
• W2120667790 hasIssue "1" @default.
• W2120667790 hasLocation W21206677901 @default.
• W2120667790 hasLocation W21206677902 @default.
• W2120667790 hasLocation W21206677903 @default.
• W2120667790 hasLocation W21206677904 @default.

• next